Prostate Cancer

Localized PCa Patients Misperceive Their Odds of Survival

Localized PCa Patients Misperceive Their Odds of Survival

Most patients have unrealistic survival expectations, which may compromise their ability to make informed treatment decisions.

Local Therapy Benefits Some Metastatic PCa Patients

Local Therapy Benefits Some Metastatic PCa Patients

By

Patients with a relatively low tumor risk and good general health status appear to experience the best survival.

Prostate, Bladder Cancer Linked to BPH

Prostate, Bladder Cancer Linked to BPH

By

In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.

Prognostic Cancer Screening Tools Show Promise

Prognostic Cancer Screening Tools Show Promise

High rates of screening for individuals with limited long-term life expectancy for all tools.

<i>BRCA</i> Gene Mutations May Influence Prostate Cancer Risk

<i>BRCA</i> Gene Mutations May Influence Prostate Cancer Risk

Multiple studies suggest they might.

Aminosalicylates Cut PCa Risk in Men with IBD

Aminosalicylates Cut PCa Risk in Men with IBD

By

Researchers found an adjusted 68% decreased risk of prostate cancer in men with IBD who used aminosalicylate.

PPIs Linked With Higher Rate of Post-RP Complications

PPIs Linked With Higher Rate of Post-RP Complications

By

Prostate cancer patients taking proton pump inhibitors also had pathologically higher stage disease.

Baseline PSA at Age 55-60 Predicts Prostate Cancer Risk

Baseline PSA at Age 55-60 Predicts Prostate Cancer Risk

By

The higher the baseline PSA levels, the greater the risk of being diagnosed with any or significant prostate cancer.

Salvage Radical Prostatectomy Offers Good Long-Term Outcomes

Salvage Radical Prostatectomy Offers Good Long-Term Outcomes

By

Minimally invasive surgery is associated with a lower incidence of bladder neck contracture.

Long-Term RP Outcomes Better for cT1a Prostate Cancer

Long-Term RP Outcomes Better for cT1a Prostate Cancer

By

Study documents superior recurrence- and metastasis-free survival compared with cT1b tumors.

Higher Radiation Dose Key to Better Brachytherapy Outcomes

Higher Radiation Dose Key to Better Brachytherapy Outcomes

By

A biologic effective dose less than 170 Gy2 is associated with a 2-fold increase risk dying from prostate cancer versus higher doses.

Erectile Function Recovery Better With Delayed Radiotherapy After RP

Erectile Function Recovery Better With Delayed Radiotherapy After RP

By

The chances of erectile function recovery improved when patients received radiation treatment more than 16 months after surgery.

Dutasteride Cuts Risk of Prostate Biopsy-Related UTIs

Dutasteride Cuts Risk of Prostate Biopsy-Related UTIs

By

In a study, use of the medication was associated with a significant 61% decreased risk.

Prostate Cancer Risk Not Increased With Testosterone Therapy

Prostate Cancer Risk Not Increased With Testosterone Therapy

By

In fact, some data suggest treatment may reduce prostate cancer incidence and aggressiveness.

Bladder Cancer Risk Higher Following Prostate Radiotherapy

Bladder Cancer Risk Higher Following Prostate Radiotherapy

By

The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.

High-Risk Prostate Cancer Linked to Poverty

High-Risk Prostate Cancer Linked to Poverty

By

In a study of African-American radical prostatectomy patients, low income predicted a higher risk of advanced stage or aggressive tumors.

Erectile Function Preserved in Half of Men Receiving Brachytherapy

Erectile Function Preserved in Half of Men Receiving Brachytherapy

By

Potency is preserved in 50.4% and 60.8% of patients at 10 years after seed implantation, according to MSSFI and SHIM scores, respectively.

Low-Carb Diet May Curb Adverse Effects of Prostate Cancer ADT

Low-Carb Diet May Curb Adverse Effects of Prostate Cancer ADT

By

New findings show metabolic changes suggesting that a carbohydrate-restricted diet may improve insulin sensitivity.

High-Grade Prostate Cancer More Likely To Be Found in Sicker Men

High-Grade Prostate Cancer More Likely To Be Found in Sicker Men

By

New study shows that heavier comorbidity burdens increase the risk of Gleason 7 or higher tumors being found at biopsy.

Mitochondrial Dysfunction Found in Black Prostate Cancer Patients

Mitochondrial Dysfunction Found in Black Prostate Cancer Patients

Mechanism may explain prostate cancer treatment resistance among African-American men.

Landmark PSA Screening Trial Results Challenged

Landmark PSA Screening Trial Results Challenged

By

The PLCO trial's conclusion that routine PSA testing does not affect prostate cancer mortality risk could be wrong.

Study Independently Validates New Prostate Cancer Grading System

Study Independently Validates New Prostate Cancer Grading System

By

Findings support the use of a 5 grade-group system that more accurately reflects patient risk of adverse outcomes.

PSA Screening More Likely Among Blacks

PSA Screening More Likely Among Blacks

The odds of PSA screening were higher among blacks than non-Hispanic whites.

Fluoroquinolones May Be Unwarranted for High PSA

Fluoroquinolones May Be Unwarranted for High PSA

By

PSA level declined by an average of 0.68 ng/mL in the treatment group.

Psychotherapy-PDE5 Inhibitor Combo Helps Post-RP Erectile Function

Psychotherapy-PDE5 Inhibitor Combo Helps Post-RP Erectile Function

By

An early, integrated approach led to less deterioration of erectile function after surgery.

Fatty Foods Possibly Contribute to Prostate Cancer Aggressiveness

Fatty Foods Possibly Contribute to Prostate Cancer Aggressiveness

Researchers also suggests that statins may help counteract harmful effect of fatty foods.

Polymer-Delivered Leuprolide Achieves Castration-Level Testosterone

Polymer-Delivered Leuprolide Achieves Castration-Level Testosterone

By

Testosterone levels of 20 ng/dL or less were achieved and maintained by more than 90% of men with advanced prostate cancer.

Better Prostate Cancer Survival With Low-Dose Aspirin?

Better Prostate Cancer Survival With Low-Dose Aspirin?

Improved odds seen for patients with colon, prostate, or breast tumors, but research isn't definitive.

Possible Biomarkers Identified for PCa Patients Treated With SBRT

Possible Biomarkers Identified for PCa Patients Treated With SBRT

Molecular pathways identified that may serve as potential biomarkers in prostate cancer treated with stereotactic body radiation therapy (SBRT).

Regular Exercise Before PCa Diagnosis May Increase Survival

Regular Exercise Before PCa Diagnosis May Increase Survival

Researchers found that men who exercised the most had the best outcomes.

Sign Up for Free e-newsletters